Latest Insider Transactions at Enfusion, Inc. (ENFN)
This section provides a real-time view of insider transactions for Enfusion, Inc. (ENFN). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Enfusion, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Enfusion, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 03
2024
|
Neal Pawar Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
26,246
-2.3%
|
$262,460
$10.09 P/Share
|
|
Dec 02
2024
|
Neal Pawar Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
21,801
-1.87%
|
$218,010
$10.03 P/Share
|
|
Nov 29
2024
|
Neal Pawar Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
19,226
-1.62%
|
$173,034
$9.92 P/Share
|
|
Oct 22
2024
|
Matthew Campobasso General Counsel |
SELL
Open market or private sale
|
Direct |
674
-1.24%
|
$5,392
$8.95 P/Share
|
|
Sep 10
2024
|
Bronwen Bastone Chief People Officer |
SELL
Open market or private sale
|
Direct |
3,219
-1.62%
|
$25,752
$8.12 P/Share
|
|
Jun 20
2024
|
Bronwen Bastone Chief People Officer |
SELL
Open market or private sale
|
Direct |
18,241
-8.4%
|
$145,928
$8.11 P/Share
|
|
Jun 18
2024
|
Valeria Gutowski Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
1,258
-3.41%
|
$10,064
$8.17 P/Share
|
|
Jun 18
2024
|
Bronwen Bastone Chief People Officer |
SELL
Open market or private sale
|
Direct |
10,539
-4.63%
|
$84,312
$8.17 P/Share
|
|
Jun 18
2024
|
Matthew Campobasso General Counsel |
SELL
Open market or private sale
|
Direct |
1,651
-2.95%
|
$13,208
$8.17 P/Share
|
|
Jun 14
2024
|
Deirdre Somers Director |
SELL
Open market or private sale
|
Direct |
4,629
-9.66%
|
$37,032
$8.4 P/Share
|
|
Jun 13
2024
|
Kathleen De Rose Director |
BUY
Grant, award, or other acquisition
|
Direct |
13,470
+18.16%
|
-
|
|
Jun 13
2024
|
Jan Hauser Director |
BUY
Grant, award, or other acquisition
|
Direct |
13,470
+18.87%
|
-
|
|
Jun 13
2024
|
Michael Spellacy Director |
BUY
Grant, award, or other acquisition
|
Direct |
13,470
+19.17%
|
-
|
|
Jun 13
2024
|
Deirdre Somers Director |
BUY
Grant, award, or other acquisition
|
Direct |
13,470
+21.93%
|
-
|
|
Jun 13
2024
|
Lawrence E Leibowitz Director |
BUY
Grant, award, or other acquisition
|
Direct |
13,470
+7.13%
|
-
|
|
May 20
2024
|
Bronwen Bastone Chief People Officer |
SELL
Open market or private sale
|
Direct |
34,059
-13.01%
|
$306,531
$9.55 P/Share
|
|
Mar 05
2024
|
Oleg Movchan Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
249,701
+21.44%
|
-
|
|
Mar 01
2024
|
Neal Pawar Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
144,176
+10.85%
|
-
|
|
Mar 01
2024
|
Oleg Movchan Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,069
-1.43%
|
$32,552
$8.67 P/Share
|
|
Mar 01
2024
|
Oleg Movchan Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
13,887
+4.66%
|
$111,096
$8.67 P/Share
|
|
Mar 01
2024
|
Bronwen Bastone Chief People Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,906
-0.72%
|
$15,248
$8.67 P/Share
|
|
Mar 01
2024
|
Bronwen Bastone Chief People Officer |
BUY
Grant, award, or other acquisition
|
Direct |
109,812
+15.37%
|
$439,248
$4.34 P/Share
|
|
Mar 01
2024
|
Matthew Campobasso General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
1,081
-1.9%
|
$8,648
$8.67 P/Share
|
|
Mar 01
2024
|
Matthew Campobasso General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
26,193
+17.58%
|
$104,772
$4.34 P/Share
|
|
Mar 01
2024
|
Bradley Herring Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,325
-0.78%
|
$18,600
$8.67 P/Share
|
|
Mar 01
2024
|
Bradley Herring Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
85,671
+12.02%
|
$342,684
$4.34 P/Share
|
|
Mar 01
2024
|
Valeria Gutowski Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,051
-2.77%
|
$8,408
$8.67 P/Share
|
|
Mar 01
2024
|
Valeria Gutowski Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
20,338
+20.29%
|
$81,352
$4.34 P/Share
|
|
Feb 29
2024
|
Matthew Campobasso General Counsel |
SELL
Open market or private sale
|
Direct |
108
-0.35%
|
$864
$8.73 P/Share
|
|
Feb 29
2024
|
Valeria Gutowski Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
27
-0.15%
|
$216
$8.73 P/Share
|
|
Jan 10
2024
|
Deirdre Somers Director |
SELL
Open market or private sale
|
Direct |
1,770
-4.88%
|
$14,160
$8.65 P/Share
|
|
Jan 09
2024
|
Bronwen Bastone Chief People Officer |
SELL
Open market or private sale
|
Direct |
410
-0.27%
|
$3,280
$8.95 P/Share
|
|
Jan 09
2024
|
Bradley Herring Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
2,090
-0.98%
|
$16,720
$8.95 P/Share
|
|
Jan 09
2024
|
Matthew Campobasso General Counsel |
SELL
Open market or private sale
|
Direct |
493
-1.57%
|
$3,944
$8.95 P/Share
|
|
Jan 09
2024
|
Oleg Movchan Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
1,355
-0.5%
|
$10,840
$8.95 P/Share
|
|
Jan 08
2024
|
Bronwen Bastone Chief People Officer |
SELL
Open market or private sale
|
Direct |
391
-0.25%
|
$3,519
$9.23 P/Share
|
|
Jan 08
2024
|
Bradley Herring Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,998
-0.93%
|
$17,982
$9.23 P/Share
|
|
Jan 08
2024
|
Matthew Campobasso General Counsel |
SELL
Open market or private sale
|
Direct |
472
-1.48%
|
$4,248
$9.23 P/Share
|
|
Jan 08
2024
|
Oleg Movchan Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
1,295
-0.48%
|
$11,655
$9.23 P/Share
|
|
Dec 14
2023
|
Oleg Movchan Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
100,000
-7.99%
|
$1,000,000
$10.01 P/Share
|
|
Dec 01
2023
|
Oleg Movchan Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
150,000
-10.7%
|
$1,500,000
$10.09 P/Share
|
|
Nov 27
2023
|
Neal Pawar Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
25,273
-2.37%
|
$227,457
$9.89 P/Share
|
|
Nov 27
2023
|
Neal Pawar Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,065,668
+28.37%
|
-
|
|
Nov 27
2023
|
Stephen Malherbe > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
1,000,000
-100.0%
|
$9,000,000
$9.86 P/Share
|
|
Nov 14
2023
|
Dan Groman Chief Technology Officer |
SELL
Open market or private sale
|
Direct |
5,000
-3.6%
|
$45,000
$9.97 P/Share
|
|
Oct 17
2023
|
Dan Groman Chief Technology Officer |
SELL
Open market or private sale
|
Direct |
5,000
-3.48%
|
$45,000
$9.09 P/Share
|
|
Sep 19
2023
|
Dan Groman Chief Technology Officer |
SELL
Open market or private sale
|
Direct |
5,000
-3.36%
|
$45,000
$9.07 P/Share
|
|
Sep 11
2023
|
Bronwen Bastone Chief People Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,182
-2.02%
|
$25,456
$8.82 P/Share
|
|
Aug 17
2023
|
Lawrence E Leibowitz Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,335
+3.76%
|
-
|
|
Aug 17
2023
|
Dan Groman Chief Technology Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
8,065
-5.14%
|
$64,520
$8.18 P/Share
|